Zorcaine Injection, Solution
Product Images NDC 0362-0830

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Zorcaine (NDC 0362-0830). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Septodont, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

0362 0830 05

0362 0830 05
Zorcaine® (articaine HCI and epinephrine) is an injection used for infiltration and nerve block anesthesia. Each dose contains 40mg of articaine hydrochloride and 1:100,000 epinephrine. It is a prescription-only medication. The text also includes some product and company information with batch number #9UIE107.*
FDA Label Image

Structural Formula (Articaine HCl)

Structural Formula (Articaine HCl)
FDA Label Image

Structural Formula (Epinephrine Bitartrate)

Structural Formula (Epinephrine Bitartrate)
FDA Label Image

Table 2 Adverse Reactions

Table 2 Adverse Reactions
Table 2 shows some adverse reactions that were observed in controlled trials of patients treated with ZORCAINE containing 1:100,000 Epinephrine. The table lists the reactions by body system and the incidence of each reaction is indicated. Common reactions include pain (13%), headache (4%), and face edema (1%). Some patients also reported digestive system issues (1%) and nervous system reactions (1%).*
FDA Label Image

Table 3 Adverse Reactions

Table 3 Adverse Reactions
This is a table showing the adverse reactions in controlled trials of patients administered with either Articaine Hydrochloride 4% containing 1:200,000 Epinephrine or Zorcaine containing 1:100,000 Epinephrine. The table lists the type of reactions and their incidence rate among patients who received the medication. The adverse reactions include pain, headache, blood aspiration, swelling, trismus, nausea and emesis, sleepiness, numbness and tingling, palpitation, ear symptoms, and cough.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.